Skip to main content
Clinical Trials/NCT01240382
NCT01240382
Completed
Phase 3

Double-masked Comparison Study of DE-089 Ophthalmic Solution in Patients With Dry Eye (Multi-center Study, in Comparison to 0.1% Sodium Hyaluronate Ophthalmic Solution) - Phase III Confirmatory Study -

Santen Pharmaceutical Co., Ltd.1 site in 1 country332 target enrollmentNovember 15, 2010

Overview

Phase
Phase 3
Intervention
3% DE-089 ophthalmic solution
Conditions
Dry Eye
Sponsor
Santen Pharmaceutical Co., Ltd.
Enrollment
332
Locations
1
Primary Endpoint
Mean Change in Fluorescein Staining Score From Baseline
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

To investigate that the efficacy of 3% DE-089 ophthalmic solution (one drop at a time, 6 times daily, 4 weeks topical administration), in comparison to 0.1% sodium hyaluronate ophthalmic solution (0.1% HA) (one drop at a time, 6 times daily, 4 weeks topical administration), is at least non-inferior in the change in fluorescein staining score, and is superior in the change in Rose bengal score, in a multicenter, double-masked, parallel-group comparison study. Safety profile will likewise be compared.

Registry
clinicaltrials.gov
Start Date
November 15, 2010
End Date
February 2008
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Those who show:
  • Keratoconjunctival disorder confirmed with vital dye staining
  • Abnormal Schirmer score results

Exclusion Criteria

  • Eye disease that needs therapy other than that for dry eye
  • Those who need to wear contact lenses during the clinical study

Arms & Interventions

3% DE-089

Intervention: 3% DE-089 ophthalmic solution

0.1% HA

Intervention: 0.1% sodium hyaluronate ophthalmic solution

Outcomes

Primary Outcomes

Mean Change in Fluorescein Staining Score From Baseline

Time Frame: Baseline and 4-week (discontinued (LOCF))

Fluorescein staining was scored according to the protocol by Shimmura et al. The cornea was divided into 3 equal zones: upper, middle, and lower. Each zone had a staining score ranging between 0 and 3 points, with minimum and maximum total staining scores ranging between 0 and 9 points. 0 is better. The degree of staining with Fluorescein dyes was scored as follows: 0 = no staining, 1= staining of less than half of the area, 2= staining of more than half of the area, 3= staining in the whole area.

Mean Change in Rose Bengal Staining Score From Baseline

Time Frame: Baseline and 4-week (discontinued (LOCF))

Rose bengal staining were scored according to the protocol by Shimmura et al. The ocular surface was divided into 5 zones: nasal and temporal conjunctival, and upper, middle, and lower corneal areas. A staining score between 0 and 3 points was used in each zone, with the minimum and maximum total staining scores ranging between 0 and 15 points.0 is better. The degree of staining with Rose bengal dyes was scored as follows: 0 = no staining, 1= staining of less than half of the area, 2= staining of more than half of the area, 3= staining in the whole area.

Study Sites (1)

Loading locations...

Similar Trials